ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Neurology

Top Neurology Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ADOLFO MILLAN M.D.

Neurology

657

$119K

87
45 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$181
Average prescription price

Avg: $204

STEVE WHEELER M.D.

Neurology

1,104

$132K

60
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$119
Average prescription price

Avg: $204

TUAN VU MD

Neurology

555

$678K

82
44 are 65+

20%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$1222
Average prescription price

Avg: $204

MARY SHRIVER D.O.

Neurology

787

$295K

113
45 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$375
Average prescription price

Avg: $204

KESTER NEDD DO

Neurology

2,740

$230K

185
81 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$84
Average prescription price

Avg: $204

WILLIAM HULLEY DO

Neurology

2,817

$544K

331
157 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 27%

$193
Average prescription price

Avg: $204

HARRIS BONNETTE M.D.

Neurology

1,546

$191K

152
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 27%

$124
Average prescription price

Avg: $204

ANGELO ALVES MD

Neurology

1,266

$183K

102
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 27%

$144
Average prescription price

Avg: $204

ERFAN ALBAKRI MD

Neurology

2,181

$250K

315
228 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$114
Average prescription price

Avg: $204

THOMAS NEWMAN MD

Neurology

1,369

$235K

207
167 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$171
Average prescription price

Avg: $204

RALPH ZWOLINSKI MD

Neurology

990

$144K

199
88 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$146
Average prescription price

Avg: $204

CHRISTOPHER POTTER MD

Neurology

994

$197K

176
130 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$198
Average prescription price

Avg: $204

LASZLO MATE M.D.

Neurology

1,433

$261K

180
130 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 4%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$182
Average prescription price

Avg: $204

REENA KAVILAVEETTIL MD

Neurology

2,085

$398K

279
179 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$191
Average prescription price

Avg: $204

RANDOLPH GESLANI M.D.

Neurology

2,410

$360K

195
96 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$149
Average prescription price

Avg: $204

MICHAEL PULLEY MD

Neurology

1,141

$401K

135
78 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$352
Average prescription price

Avg: $204

NICHOLAS AVGEROPOULOS MD

Neurology

797

$159K

112
38 are 65+

16%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 27%

$199
Average prescription price

Avg: $204

MICHAEL NOVAK M.D.

Neurology

3,680

$556K

451
378 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 4%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$151
Average prescription price

Avg: $204

RALPH GONZALEZ M.D.

Neurology

2,269

$777K

288
193 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$343
Average prescription price

Avg: $204

JEFFREY GELBLUM MD

Neurology

1,455

$288K

154
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

49%
prescriptions for brand name drugs

Avg: 27%

$198
Average prescription price

Avg: $204

ROBERT SCHIFTAN MD

Neurology

711

$62.7K

96
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$88
Average prescription price

Avg: $204

WILLIS DICKENS MD

Neurology

922

$86.4K

142
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$94
Average prescription price

Avg: $204

MOHAMMED CHOUDHRY MD

Neurology

2,304

$353K

394
328 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 27%

$153
Average prescription price

Avg: $204

BRIAN STEINGO MD

Neurology

3,328

$4.33M

310
98 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

43%
prescriptions for brand name drugs

Avg: 27%

$1301
Average prescription price

Avg: $204

LINDA PAO MD

Neurology

4,783

$880K

505
456 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$184
Average prescription price

Avg: $204

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank